Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices

Liver Int. 2016 Feb;36(2):240-5. doi: 10.1111/liv.12916. Epub 2015 Sep 6.

Abstract

Background/aims: Endoscopic screening for high-risk gastro-oesophageal varices (GOV) is recommended for compensated cirrhotic patients with transient elastography identifying increasing numbers of patients with cirrhosis without portal hypertension. Using liver stiffness measurement (LSM) ± platelet count, the aim was to develop a simple clinical rule to exclude the presence of high-risk GOV in patients with Child-Pugh A cirrhosis.

Methods: A retrospective analysis of 71 patients with Child-Pugh A cirrhosis diagnosed by transient elastography (LSM >13.6 kPa) who underwent screening gastroscopy was conducted. A predictive model using LSM ± platelet count was assessed to exclude the presence of high-risk GOV (diameter >5 mm and/or the presence of high-risk stigmata) and validated using a second cohort of 200 patients from two independent centres.

Results: High-risk GOV were present in 10 (15%) and 16 (8%) of the training and validation cohorts, respectively, which was associated with LSM and Pl count (P < 0.05). A combined model based on LSM and Pl count was more accurate for excluding the presence of high-risk GOV than either alone (training cohort AUROC: 0.87 [0.77-0.96] vs. 0.78 [0.65-0.92] for LSM and 0.71 [0.52-0.90] for platelets) with the combination of LSM ≤25 kPa and Pl ≥100 having a NPV of 100% in both the training and validation cohorts. A total of 107 (39%) patients meet this criterion.

Conclusion: The combination of LSM ≤25 kPa and Pl ≥100 can be used in clinical practice to exclude the presence of high-risk GOV in patients with Child-Pugh A cirrhosis.

Keywords: cirrhosis; elastography; hepatitis C virus; portal hypertension; surveillance.

MeSH terms

  • Aged
  • Elasticity Imaging Techniques / methods*
  • Endoscopy, Digestive System / methods
  • Esophageal and Gastric Varices* / diagnosis
  • Esophageal and Gastric Varices* / etiology
  • Female
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / diagnosis
  • Male
  • Middle Aged
  • Platelet Count / methods*
  • Reproducibility of Results
  • Risk Assessment / methods